About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Half-normal Saline in Atrial Fibrillation Ablation | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNANCT03498586

Half-normal Saline in Atrial Fibrillation Ablation

The study evaluates the use of half-normal saline as an irrigant for open-irrigated catheters during atrial fibrillation ablation. By increasing the efficacy of radiofrequency energy-mediated lesion f...

Lead sponsor: Texas Cardiac Arrhythmia Research Foundation•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Texas Cardiac Arrhythmia Research Foundation

Age

18 - 75 years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•male or female between 18 and 75 years of age at the time of enrollment
•undergoing first-time radiofrequency ablation for atrial fibrillation
•written informed consent obtained from subject or subject's legal representative and ability for subject to comply with the requirements of the study

Exclusion Criteria

•robotic-guided atrial fibrillation ablation
•baseline hyponatremia (serum sodium level \< 135 mEq/L)
•pregnant, breastfeeding, or unwilling to practice birth control during participation in the study
•presence of a condition or abnormality that in the opinion of the Investigator would compromise the safety of the patient or the quality of the data

Related studies

RECRUITINGPhase 3

Stroke and Systemic Embolism Prevention in Adult Participants With Atrial Fibrillation for Whom Oral Anticoagulation is Unsuitable

NCT07430956 · Atrial Fibrillation (AF)

A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation

NCT07527299 · Atrial Fibrillation

RECRUITINGPhase 4

Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI

NCT04695106 · Atrial Fibrillation, Antithrombotic Therapy, and more

Catheter Ablation Plus LAAO Versus Anticoagulation in Frail Elderly Patients With Atrial Fibrillation

NCT07441382 · Atrial Fibrillation (AF), Stroke, and more

Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation

NCT06784466 · Atrial Fibrillation (AF), Persistant Atrial Fibrillation, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: April 5, 2022Terms

Trial snapshot

StatusCOMPLETED

PhaseNA

Enrollment99

Start dateMay 2018

Last updatedApr 5, 2022

Condition

Atrial Fibrillation

Locations shown

Texas Cardiac Arrhythmia Institute, St. David's Medical Center

Austin, Texas

Sunnybrook Health Sciences Centre

Toronto, Ontario

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 5, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions